Clay Siegall Dedication to Cancer Therapy

Clay Siegall is the co-founder and CEO of the Seattle Genetics. As the top leading cause of death in the globe, Siegall is committed to finding a cure for cancer. He has made significant achievements in developing an Antibody Drug Conjugate (ADC’s) through his leadership in the firm. The drug selectively destroys the cancer cells and leaves the healthy cells active. Besides producing the ADC’s, they have pooled their footprints to increase the use of Adcetris to other diseases apart from cancer.

Adcetris is mostly used for cancer treatment, and it is the main drug manufactured by the business. Clay Siegall says that they have tested the drug on lymphomas for seventy different cases. The company also has the plan to add more personnel to produce more Adcetris drugs. Today the firm has more than eight hundred workers. Furthermore, they have expanded their growth strides to building twenty offices in Switzerland.

His quest for providing support to individuals and research activities has led the company to be one of the leading firms in the cancer investigation community. He has the mindset of ending cancer in the future. Moreover, he also wishes to unleash more twelve cancer drugs. This has been a source of hope for the people living with cancer. His vast experience from the different sectors he has served has allowed him to lead his company in the successful paths. For instance, Clay Siegall has worked with the Nation Institute of Health and Cancer.

About the Seattle Genetics

The biotechnological firm led by Siegall produces preclinical and clinical products. It was launched in 1998 and has been providing innovative cancer drugs, the ADC’s over the years. It has worked in partnership to research, provide scientific innovation and drug advancement activities. This includes partners like Genentech, Curagen, Bayer Pharmaceuticals Corporation and Medimmune.

The Seattle Genetics CEO is appointed as a Mirna Therapeutics Company’s Board of Director

Mirna announced the appointment of Clay Siegall as the Board of Directors’ member and outside director in 2013. Founded in 2007, the Company is focused on therapeutics microRNA. With the presence of Dr. Clay in the firm, they are currently into cancer research. Dr. Paul Lammers, the CEO of Mirna says that they are excited to have an experienced man around their activities. They have high expectation from Dr. Clay to guide them in the microRNA therapeutics advancements.

Seattle Genetics Wants To Keep Cancer Patients Going

Seattle Genetics wants to keep as many of their patients alive as they can when they work with doctors around the country who are members of their drug trials. The drug trials that are most interesting to patients are the ones where they can get something that is specific to them. Seattle Genetics was started as a way for Clay Siegall to reach people who were in need of better medications, and he has been working on these plans for a long time to help people. His antibody based drugs are very powerful, and he has been sending out trial drugs to doctors who are trusting in him every day. He has shown that someone can recover with better drug therapy.

Drug therapy is something that people need to try when they have been diagnosed with cancer, and it is important that people are able to try something that will make them feel better. The cancer drugs that were created by Clay Siegall are sold by Seattle Genetics, and he pulled together a very big company that has a lot of money to work with. They are selling so well that they can do well to help more people by making new drugs.

The new drugs that people get from Seattle Genetics could number up to twelve, and that could address a lot of different kinds of cancer that people have been fighting. Someone who is struggling with cancer needs to be sure that they have asked their doctors if they have more options for them. The options that someone has will change their outlook, and Seattle Genetics wants to help everyone get a better treatment plan. The plan that people get from their doctor that includes Seattle Genetics is a lot more powerful and helpful than anything else on the market.

Learn more about Siegall:

http://www.bloomberg.com/research/stocks/people/person.asp?personId=607509&privcapId=34145